Biotechnology · Healthcare
Board Member
2021-06-09–present
Board Member
Nautilus Biotechnology, Inc. (NAUT)Equibles does not estimate personal net worth.
Get an email with a short summary when Nautilus Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get NAUT alertsMatthew Posard is recorded as Board Member at Nautilus Biotechnology, Inc. (NAUT) since June 9, 2021. Nautilus Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nautilus Biotechnology, Inc. includes Sujal Patel (CEO and Board Member), Anna Mowry (CFO), Matt Murphy (General Counsel) and 7 others.
2021-06-09–present
Biotechnology · Healthcare
Board Member
2021-06-09–present
No call appearances or filed executive changes recorded yet.